Amia Capital LLP Voyager Therapeutics, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$7.15 - $12.28 $104,618 - $179,680	-14,632 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $4,384 - $6,022	-438 Reduced 2.91%	14,632 $156,000
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $66,734 - $117,800	-8,290 Reduced 35.49%	15,070 $190,000
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $25,003 - $53,904	3,677 Added 18.68%	23,360 $214,000
Q4 2019 Feb 13, 2020	BUY	$12.82 - $16.85 $252,336 - $331,658	19,683 New	19,683 $275,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $222M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.